THERAPEUTICSMD INC's ticker is TXMD and the CUSIP is 88338N107. A total of 158 filers reported holding THERAPEUTICSMD INC in Q3 2018. The put-call ratio across all filers is 0.79 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $1,409,000 | -3.7% | 541,815 | +131.2% | 0.06% | +1.8% |
| Q2 2018 | $1,463,000 | -35.9% | 234,384 | -50.0% | 0.06% | -37.1% |
| Q1 2018 | $2,283,000 | -10.0% | 468,769 | +11.6% | 0.09% | -9.2% |
| Q4 2017 | $2,537,000 | +134.9% | 420,000 | +124.5% | 0.10% | +113.0% |
| Q4 2016 | $1,080,000 | -48.4% | 187,100 | -39.1% | 0.05% | -42.5% |
| Q3 2016 | $2,091,000 | -82.0% | 307,000 | -79.3% | 0.08% | -81.0% |
| Q2 2015 | $11,645,000 | +29.9% | 1,481,500 | 0.0% | 0.42% | +18.6% |
| Q1 2015 | $8,963,000 | – | 1,481,500 | – | 0.36% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| 1492 Capital Management LLC | 387,529 | $2,341,000 | 1.83% |
| SANDERS MORRIS HARRIS LLC | 521,500 | $3,150,000 | 1.33% |
| Newtyn Management, LLC | 1,250,000 | $7,550,000 | 1.15% |
| ARDSLEY ADVISORY PARTNERS LP | 1,050,000 | $6,342,000 | 0.77% |
| NEXTHERA CAPITAL LP | 528,351 | $3,191,000 | 0.59% |
| MORGENS WATERFALL VINTIADIS & CO INC | 112,000 | $676,000 | 0.53% |
| Capital Impact Advisors, LLC | 200,707 | $1,212,000 | 0.52% |
| SPHERA FUNDS MANAGEMENT LTD. | 479,980 | $2,899,000 | 0.34% |
| Rock Springs Capital Management LP | 1,175,000 | $7,097,000 | 0.32% |
| QCM Cayman, Ltd. | 11,493 | $69,000 | 0.29% |